Perspectives in Immunotherapy: meeting report from the Immunotherapy Bridge, December 1st–2nd, 2021

Over the past decade, immunotherapy has become an increasingly fundamental modality in the treatment of cancer. The positive impact of immune checkpoint inhibition, especially anti-programmed death (PD)-1/PD-ligand (L)1 blockade, in patients with different cancers has focused attention on the potent...

Descripción completa

Detalles Bibliográficos
Autores principales: Ascierto, Paolo A., Avallone, Antonio, Bhardwaj, Nina, Bifulco, Carlo, Bracarda, Sergio, Brody, Joshua D., Buonaguro, Luigi, Demaria, Sandra, Emens, Leisha A., Ferris, Robert L., Galon, Jérôme, Khleif, Samir N., Klebanoff, Christopher A., Laskowski, Tamara, Melero, Ignacio, Paulos, Chrystal M., Pignata, Sandro, Ruella, Marco, Svane, Inge Marie, Taube, Janis M., Fox, Bernard A., Hwu, Patrick, Puzanov, Igor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Meeting Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9172186/
https://www.ncbi.nlm.nih.gov/pubmed/35672823
http://dx.doi.org/10.1186/s12967-022-03471-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9172186/
https://www.ncbi.nlm.nih.gov/pubmed/35672823
http://dx.doi.org/10.1186/s12967-022-03471-y

Ejemplares similares